National Institute of Allergy and Infectious Diseases (NIAID)
The purpose of this Notice is to inform the extramural community that NOT-AI-20-031, Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19), will be rescinded as of May 19, 2020.
In place of NOT-AI-20-031, NIAID has issued NOT-AI-20-051, Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19); this new NOSI has a narrower research focus and directs interested applicants to the following funding opportunity announcements:
Applicants interested in pursuing NIH grant support for SARS-CoV-2/COVID-19 using either the R01 or R21 funding mechanisms are encouraged to consider the following recently published FOAs, which provide an expedited funding mechanism:
Diane Post, Ph.D.
Division of Microbiology and Infectious Diseases
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3348
Email: postd@niaid.nih.gov
Michael Minnicozzi, Ph.D.
Division of Allergy, Immunology, and Transplantation
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3532
Email: NIAID.SARS2.NOSI@niaid.nih.gov